Member Info for Techtonic

Cheers, Davey

Picked up 4x 500k and a 250 early this morning at 0.63 then dumped them at the close of play at 0.62.

Probably hoping to push the price higher today, or maybe MM games

Total joke company. Possibly the worst on the Market, or in the Top Ten.

First they worked for more than a decade on a repurposed drug that hadn't cared to ask anyone in big pharma whether they wanted. They didn't.

Then they realised retrospectively that day probably should get orphan drug status after 10 years or so - during which the share price lost 99% of value and ALL the staff left.

Now they announce something they mentioned last year...but it's so formative stage it's almost before conception!

So NFX have now decided to talk to the tea boy, in prelim talks to get them into the office, to presubmit a tentative question to the office manager, so he can formulate a formal submission which then can be made.

Ace!

I've got to give it to you Daniel (and I can see you're on advfn doing the same too), for a newbie ramper you're certainly giving it some.

But obviously not conversant with the overall picture.

Even with a JV , as you call it, and CLAI, the revenues by Ciz-bio's own figures are a paltry $30million by year 3.

And you state the test is "95% effective in diagnosing lung cancer".

Actually if you take into account the false positives , it's way less than this.

In fact, the raw data (which you obviously know nothing about) at the last airing , gave a best 'accuracy' of 51%.

But there has been discussions on here on how the test may have been modified to give better results.

And I certainly concur that with CLAI accreditation RNS , the share price should get a big boost, especially if they link this with some sort of launch in China.

If that £50K buy sticks.

These pre-delisting shares do tend to fill the gap

I'm hoping for trades to take this to at least double where we are - maybe even treble

Get shafted once again!

99% of posts on here today totally wrong or misleading.

Always beware a pump RNS shortly after a fundraise.

Although got to hand it to the feckless ramping crew for feeding me a few quid.

I'm liking the recent appointments and things seem to be moving in the right direction..

New NE Director sees potential and I like his quote: "I believe Nuvec will drive long-term value through licensing deals and partnerships in the NEAR term".

I'm taking it that he is privy to all the background data and negotiations.

Stockwatch..

It can hardly be a pump and dump when there's been such a massive material increase in Mindflair's value

Happy to oblige, Joey .

£12.50 by 4.30pm.

Minimum.

Bid came down to 1.4325 briefly, but MMs left offer up at 1.58p.

There may be another dip before news...depends on the sloth-like nature of Ciz. Nothing up to date has been remotely on time.

Haha...what did I tell you Joey.

You never learn

Hi Joey,

Absolute bottom seems to be 1.44p.

I'm expecting a little quick drop down to that level again before news. May presenter possibility for someone quick off the Mark to get in around 1.5p imo

What tends to happen is the directors get in at rock bottom prices...they sweep up at the expense of shareholders for when it goes private.

Not saying that is happening here for sure but watch out for some Tr1s next few days.

I've bought a few for a pair but as usually bounces quite strongly at some point before delist.

There's still a market to make

Happy New Year Green and everyone. Hope it's happy, healthy and financially good for you all😁

With all due respect , Green, the latest data on Specificity (from the 2024 'pitch' for cash) , ranged between 45% and 87%

But combined with the best sensitivity of 92%, came in at 61%

When the sensitivity dropped to an unusable 50%, the specificity came in at 87.

Hmm..still think the continual omission of specificity results can only mean one thing - they're bad, at circa 40-61% as in tests.

I think this will be the downfall of this test, as other more accurate tests are developed (and don't ask me which ones! There's been at least two mentioned in the last few months)

At year 3 when Ciz gets minimal revenue, the wise money will be going elsewhere - unless Ciz can manage to get a portfolio of tests under their belt. Possible .

Still think it'll de-list / go private / be subsumed by US at some point. Number of companies going private is quite shocking actually. (Anyway I doubt this will be in the near term anyway)

Sorry for everyone who has been stung here.

But these shares do tend to rebound after the announcement of going private.

It may even fill the gap shortly back up to the original price

Had to ponder for a while what you meant there OAPK..

Cavendish? For fundraise?

I'm definitely lower down the food chain than that!

Nope, I'm just guessing with cashburn etc. it's got to be soonish

Hi OAPk..

I would be amazed if they don't RNS a fundraise in the next two weeks..

The cash must be almost on fumes now.

I'm guessing they've been hoping for FDA approval to raise at a higher price..

But... revenue still only £2.7 - 3M, loss still approx £5 million..

£4mill raised last December.

Oops sorry. I'm actually being too generous to Cizzle.

The best data at a certain threshold (best) was Sensitivity 92, specificity 61..making 1.53

Now whether they have improved this somehow is open to conjecture, since the company is extremely shareholder unfriendly with info

;o)) required for first sentence .. 🤔